BioCentury
ARTICLE | Company News

Genetics Institute, SciGenics Inc. deal

December 11, 1995 8:00 AM UTC

GENIZ completed its tender offer for the 2.1 million SCGN shares outstanding at $14 per share (see BioCentury Oct. 16). SCGN is now a wholly owned subsidiary of GENIZ. ...